Literature DB >> 26231270

Overview of the International Classification of Vestibular Disorders.

Alexandre R Bisdorff1, Jeffrey P Staab2, David E Newman-Toker3.   

Abstract

Classifications and definitions are essential to facilitate communication; promote accurate diagnostic criteria; develop, test, and use effective therapies; and specify knowledge gaps. This article describes the development of the International Classification of Vestibular Disorders (ICVD) initiative. It describes its history, scope, and goals. The Bárány Society has played a central role in organizing the ICVD by establishing internal development processes and outreach to other scientific societies. The ICVD is organized in four layers. The current focus is on disorders with a high epidemiologic importance, such as Menière disease, benign paroxysmal positional vertigo, vestibular migraine, and behavioral aspects of vestibular disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bárány Society; Classification; Symptoms; Vertigo; Vestibular

Mesh:

Year:  2015        PMID: 26231270     DOI: 10.1016/j.ncl.2015.04.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  41 in total

1.  Low-intensity ultrasound activates vestibular otolith organs through acoustic radiation force.

Authors:  M M Iversen; D A Christensen; D L Parker; H A Holman; J Chen; M J Frerck; R D Rabbitt
Journal:  J Acoust Soc Am       Date:  2017-06       Impact factor: 1.840

2.  Vestibular function in panic disorder patients: a vestibular-evoked myogenic potentials and video head impulse test study.

Authors:  G Angov; E Mihaylova-Angelova; D Petrova; Katerina Stambolieva
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-28       Impact factor: 2.503

Review 3.  Clinical value of the video head impulse test in patients with vestibular neuritis: a systematic review.

Authors:  Leonardo Manzari; Alessandro Antonio Princi; Sara De Angelis; Marco Tramontano
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-24       Impact factor: 2.503

4.  Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea.

Authors:  Hyo-Jung Kim; Ja-Ok Lee; Jeong-Yoon Choi; Ji-Soo Kim
Journal:  J Neurol       Date:  2020-04-16       Impact factor: 4.849

5.  Referral trajectories in patients with vertigo, dizziness and balance disorders and their impact on health-related quality of life and functioning: results from the longitudinal multicenter study MobilE-TRA.

Authors:  Benedict Katzenberger; Daniela Koller; Ralf Strobl; Rebecca Kisch; Linda Sanftenberg; Karen Voigt; Eva Grill
Journal:  J Neurol       Date:  2022-03-30       Impact factor: 4.849

6.  The development of a new questionnaire for cognitive complaints in vertigo: the Neuropsychological Vertigo Inventory (NVI).

Authors:  Emilie Lacroix; Naima Deggouj; Samuel Salvaggio; Valérie Wiener; Michel Debue; Martin Gareth Edwards
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-22       Impact factor: 2.503

Review 7.  Genetic contribution to vestibular diseases.

Authors:  Alvaro Gallego-Martinez; Juan Manuel Espinosa-Sanchez; Jose Antonio Lopez-Escamez
Journal:  J Neurol       Date:  2018-03-26       Impact factor: 4.849

Review 8.  Current Treatment Options: Vestibular Migraine.

Authors:  Clinton G Lauritsen; Michael J Marmura
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

9.  Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern China.

Authors:  Peng Liu; Shaolin Ma; Guixiang Du; Shengde Sun; Xin Zhang; Peng Tang; Chen Hou; Yue Liu; Jiaxing Zhao; Xiaohui Zhang; Li Chen; Chaochao Gu; Lina Zhang; Li Chong; Xu Yang; Rui Li
Journal:  J Gen Intern Med       Date:  2021-01-26       Impact factor: 6.473

10.  Recurrent Vestibular Symptoms Not Otherwise Specified: Clinical Characteristics Compared With Vestibular Migraine and Menière's Disease.

Authors:  Julia Dlugaiczyk; Thomas Lempert; Jose Antonio Lopez-Escamez; Roberto Teggi; Michael von Brevern; Alexandre Bisdorff
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.